-
Why It Matters That The Coronavirus Is Changing – And What This Means For Vaccine Effectiveness
A new variant of SARS-CoV-2 is spreading rapidly in the United Kingdom, with over 1,400 cases since September. SARS-CoV-2, the virus that causes COVID-19,… -
‘Harm Reduction’ May Be Best Approach For COVID And Holidays, Says Boston Medical Center Addiction Specialist
When it comes to COVID and Christmas, harm reduction means acknowledging that not all activities that are discouraged from public health officials are created equal. -
The Case For Rapid Tests
Expanding rapid testing for COVID-19 in the U.S. has been anything but rapid. Here’s why. -
FDA Advisers Weigh Pfizer's COVID-19 Vaccine
Experts will assess the benefits and risks of authorizing what could be the first COVID-19 vaccine for emergency use in the U.S. -
CDC Adviser On COVID-19 Vaccine Priority Groups And Why Some Aren't Eager To Be First
Dr. Robert Atmar, a member of the CDC's Advisory Committee on Immunization Practices, says he's hearing hesitancy among some front line medical workers about being first in line for a vaccine. -
More Good News For Moderna's COVID-19 Vaccine Candidate
Biotech company Moderna has new data reinforcing that its COVID-19 inoculation is safe and effective. The company is submitting an application to the FDA Monday requesting emergency use authorization. -
Black People Are More Hesitant About A Vaccine. A Leading Nurse Wants To Change That
Ernest Grant, the president of the American Nurses Association, says historical abuses have left Black people with a distrust of vaccines. Now he's part of a coronavirus vaccine trial. -
U.K. Coronavirus Trial Promises 'Highly Effective' New Vaccine
Pharmaceutical company AstraZeneca made the announcement on Monday, saying that one dosing regimen showed the drug was 90% effective in preventing infection. -
Development Of COVID-19 Vaccine And Treatment 'Have To Happen Side By Side'
Dr. Mansoor Amiji, Northeastern University pharmaceutical sciences and chemical engineering professor, says companies are working on ways to both treat and prevent the virus. -
2nd Virus Vaccine Shows Overwhelming Success In U.S. Tests
Moderna said its vaccine appears to be 94.5% effective, according to preliminary data from an ongoing study.
